Growth Metrics

Novartis Ag (NVS) Operating Income Growth (5y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -1.10%
Dec 31, 2023 87.04%
Jun 30, 2023 18.38%
Mar 31, 2023 -4.85%
Dec 31, 2022 -2.19%
Sep 30, 2022 -0.68%
Jun 30, 2022 15.50%
Mar 31, 2022 2.81%
Dec 31, 2021 -44.80%
Sep 30, 2021 4.45%
Jun 30, 2021 71.16%
Mar 31, 2021 1,452.44%
Dec 31, 2020 11.49%
Sep 30, 2020 25,108.85%
Mar 31, 2020 -957.66%
Mar 31, 2019 1,222.82%
Sep 30, 2017 1,510.47%
Jun 30, 2017 2,124.05%
Mar 31, 2017 1,467.03%
Dec 31, 2016 2,366.69%
Sep 30, 2016 1,496.80%
Jun 30, 2016 1,492.51%
Mar 31, 2016 -7.97%
Dec 31, 2015 1,376.32%
Sep 30, 2015 -93.82%
Mar 31, 2015 -37.31%
Dec 31, 2014 -49.79%
Sep 30, 2014 -32.07%
Mar 31, 2014 -22.08%